Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Gonorrhea Clinical Trials Market Overview
The Gonorrhea clinical trial report consists of 338 trials. The report provides an overview of the Gonorrhea clinical trials scenario. The report provides top-line data relating to the clinical trials on Gonorrhea. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report includes the names of prominent sponsors involved with conducting the Gonorrhea clinical trials as well.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · Others |
Key Countries | · China
· Russia · The US · South Korea · Iran · Thailand |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · AVVA Rus
· Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd · Anhui Anke Biotechnology (Group) Co Ltd · Abbott Laboratories · Melinta Therapeutics LLC · Aurobindo Pharma Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Gonorrhea Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the Gonorrhea clinical trials landscape with more than 57% of the clinical trials conducted there as of October 2023.
The key regions considered for Gonorrhea clinical trials analysis are Asia-Pacific, Europe, North America, and the Middle East and Africa, among others.
In a country-wise analysis, as of October 2023, China accounted for the highest number of Gonorrhea clinical trials, followed by Russia and the US.
G7 countries: Among the G7 (United States, United Kingdom, Germany, Canada, Japan, France, and Italy) countries, the US has the highest proportion of Gonorrhea to Infectious Disease clinical trials as of October 2023.
E7 countries: Among the E7 (China, India, Russia, Turkey, Brazil, Mexico, and Indonesia) countries, Russia has the highest proportion of Gonorrhea to Infectious Disease clinical trials as of October 2023.
Gonorrhea Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Gonorrhea Clinical Trials
Gonorrhea Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Gonorrhea clinical trials are company, institution, and the government. As of October 2023, the company sponsor type dominated the Gonorrhea clinical trials share, followed by institution.
Gonorrhea Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy Full Report for More Sponsor Type Insights into Gonorrhea Clinical Trials
Gonorrhea Clinical Trials - Competitive Landscape
In 2023, AVVA Rus and Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have conducted the highest number of Gonorrhea clinical trials.
Some of the leading sponsors for Gonorrhea clinical trials are:
- AVVA Rus
- Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
- Anhui Anke Biotechnology (Group) Co Ltd
- Abbott Laboratories
- Melinta Therapeutics LLC
- Aurobindo Pharma Ltd
Gonorrhea Clinical Trials Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More about the Leading Players of Gonorrhea Clinical Trials
Segments Covered in the Report
Gonorrhea Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- Others
Gonorrhea Clinical Trials Country Outlook (2023)
- China
- Russia
- The US
- South Korea
- Iran
- Thailand
Gonorrhea Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Anhui Anke Biotechnology (Group) Co Ltd
Abbott Laboratories
Melinta Therapeutics LLC
Aurobindo Pharma Ltd
Harbin Pharmaceutical Group Co Ltd
Melinta Therapeutics Inc (Inactive)
Novartis AG
Sandoz Group AG
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Gonorrhea clinical trials?
Asia-Pacific accounted for the highest number of Gonorrhea clinical trials as of October 2023.
-
Which country conducted the highest number of Gonorrhea clinical trials?
China conducted the highest number of Gonorrhea clinical trials as of October 2023.
-
Which sponsor type was the most prominent in the Gonorrhea clinical trials?
Company was the most prominent sponsor type for Gonorrhea clinical trials.
-
Who are the leading sponsors of Gonorrhea clinical trials?
Some of the leading sponsors of Gonorrhea clinical trials are AVVA Rus, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, Anhui Anke Biotechnology (Group) Co Ltd, Abbott Laboratories, Melinta Therapeutics LLC, and Aurobindo Pharma Ltd, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.